Nirvana Life Sciences Inc.
NIRV
CNSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -267.10K | -246.50K | -260.90K | -397.60K | -338.10K |
| Total Depreciation and Amortization | -- | -- | -- | 4.50K | 13.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.30K | 11.50K | 11.50K | 136.10K | 47.00K |
| Change in Net Operating Assets | -491.90K | -509.30K | 199.50K | 220.80K | 245.10K |
| Cash from Operations | -768.20K | -744.10K | -49.70K | -36.00K | -32.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 93.90K | 69.90K | 70.20K | 4.60K | 49.50K |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -35.80K | 50.00K |
| Issuance of Common Stock | 950.00K | 950.00K | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -59.10K | -59.10K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -800.00 | -800.00 | -- | 9.10K | 9.10K |
| Cash from Financing | 758.10K | 741.30K | 50.60K | -55.80K | 36.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 11.60K | 1.80K | -400.00 | 84.30K | -11.30K |
| Net Change in Cash | 1.60K | -1.00K | 500.00 | -7.50K | -7.40K |